In vivo antiplasmodial and toxicological effect of crude ethanol extract of Echinops kebericho traditionally used in treatment of malaria in Ethiopia by Alemayehu Toma et al.
Toma et al. Malaria Journal  (2015) 14:196 
DOI 10.1186/s12936-015-0716-1RESEARCH Open AccessIn vivo antiplasmodial and toxicological effect of
crude ethanol extract of Echinops kebericho
traditionally used in treatment of malaria in
Ethiopia
Alemayehu Toma1*, Serawit Deyno1, Abrham Fikru2, Amalework Eyado3 and Andrew Beale4Abstract
Background: Medicinal plants have contributed significantly to current malaria treatment. Emergence of resistance to
currently available drugs has necessitated the search for new plant-based anti-malarial agents and several plant-based,
pharmacologically active anti-malarial compounds have been isolated. This study was conducted to validate the
traditional usage of Echinops kebericho for treating malaria in the traditional health care system of Ethiopia.
Methods: The roots of E. kebericho were collected from Masha Woreda, Sheka Zone. After collection, the plant
materials were identified by a taxonomist, dried under shade and crushed to powder for extraction. The powdered
roots were extracted by maceration using 70 % ethanol. Acute toxicity study of the crude extract was carried out in
Swiss albino mice. The in vivo anti-malarial activity of plant extract (200, 350 and 500 mg/kg) of E. kebericho roots
against a chloroquine (CQ) sensitive strain of Plasmodium berghei strain ANKA was assessed using the four-day
suppressive test procedure. Parameters such as parasitaemia, packed cell volume, body weight and survival time were
then determined using standard tests.
Results: Oral administration of the ethanol extract showed significant (P <0.001) parasitaemia suppression at dose
levels of 350 and 500 mg/kg in dose-related manner compared with the negative control. Five hundred mg/kg
showed the highest (57.29 ± 1.76 %) parasitaemia suppression. The survival times of P. berghei-infected mice were also
increased in a dose-dependent manner but the test material did not prevent weight loss associated with increased
parasitaemia. The result also showed the plant material prevented the loss in packed cell volume associated with
increased parasitaemia. Its oral LD50 was found to be greater than 5,000 mg/kg, indicating its wider safety margin in
mice.
Conclusion: The result revealed the ethanol extract of E. kebericho roots has anti-malarial activity against P. berghei in
an animal model and lends support to the use of the plant to combat malaria in Ethiopian folk medicine. Further
work is necessary to isolate, identify and characterize the active principles from the plant material.
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Malaria, one of the oldest human diseases, has become
the main concern of the World Health Organization
(WHO) in the past few decades, not only as a result of
its re-emergence as the biggest infectious killer, but also
expansion of its distribution to previously non-affected
areas [1]. In Ethiopia, for example, the lowlands have
always been regarded as areas of high malaria transmis-
sion, however, this appears to be changing due to climatic
and ecological changes [2, 3]. Recently the epidemic
spread into the highland areas where a large proportion
of the population lives [4].
The resurgence of the disease due to drug-resistant
strains of the parasite and insecticide-resistant strains
of the mosquito vector catches the attention of many
scholars. As a result of which, there have been various
efforts to combat the problem of parasite resistance,
including reversing chloroquine resistance, use of com-
bination therapy, and discovery of new anti-malarial
compounds from various sources, especially from trad-
itional medicinal plants [5, 6].
Traditional medicinal plants have contributed signifi-
cantly to current malaria treatment. The first effective
drug treatment against malaria was quinine, which was
extracted from the Cinchona tree. The chemical structure
of quinine was used to synthesize new anti-malarial
drugs, such as chloroquine and primaquine. The import-
ance of plants as effective anti-malarial was further rein-
forced by the isolation of artemisinin from the Chinese
medicinal plant, Artemisia annua (Family Asteraceae).
Artemisinins are presently the most effective drug against
multi-drug resistant strains of Plasmodium falciparum.
Several pharmacologically active anti-malarial compounds
have been in development from East African medicinal
plants including Ethiopia [7].
The genus Echinops is reported to comprise over 120
species, of which four (Echinops kebericho Mesfin, Echi-
nops buhaitensis, Echinops ellenbeckii, and Echinops long-
isetus) are confined to the Ethiopian highlands. Echinops
kebericho (local Amharic name: kebercho) is traditionally
used for the treatment of fever, diarrhoea, malaria, as
taenicide, stomach ache, and typhus [8–11]. Moreover,
the smoke from burning the plant is inhaled to relieve
headache and as a cure for “evil eye” (possession by evil
spirits in Ethiopian folk religion). The smoke is inhaled
to fight typhus and fever, and is known to be used as a
fumigant for mosquitoes and as a snake repellent. The
traditionally used preparation varies among society. In-
halation for pain relief and oral chewed preparation for
malaria, diarrhoea and stomach ache among the different
preparation used in traditional medicine [9, 10]. Extracts
and essential oils of the roots of E. kebericho have been
assessed for their antimicrobial, antihelmintic and mollus-
cicidal activities [12]. Although the plant is in use for thetreatment of malaria in Ethiopian society, there is no
laboratory-based evidence for the effectiveness and safety
of the plant. This study is, therefore, designed to evaluate
the in vivo anti-malarial activity and acute toxicity test of
the ethanol extract of E. kebericho.
Methods
Chemicals
The chemicals used were absolute ethanol (Reagent
Chemical-Ltd, China), Giemsa stain 10 % (Shenyang Xin
Guang, China), chloroquine phosphate (Ethiopian Phar-
maceutical Manufacturing, Ethiopia).
Collections and preparation of plant materials
The roots of E. kebericho were collected from Masha
Woreda, Sheka Zone South Nation’s Nationalities and
Peoples Region. After collection, the plant materials were
identified by a taxonomist and a voucher specimen (AL
001) was deposited at Addis Ababa University (AAU)
Herbarium, dried under shade and crushed to powder for
extraction.
Extraction
The powdered roots were extracted by maceration
using 70 % ethanol. Next, the mixture was filtered using
Whatmann filter paper No. 1. The filtered extract was
made ethanol-free by evaporating it using rotary evapor-
ator under reduced pressure. The actual yield expressed
in weight by weight (w/w) was 13.2 %. The filtrate ob-
tained was kept refrigerated at 8 °C and fresh solution
was prepared for each experiment by using 3 % tween 80.
Laboratory animal preparation
Healthy adult male Swiss albino mice weighing 25–32 g
at six to eight weeks age were used in this study. All ani-
mals were housed in standard cages in the animal house
and fed a standard pellet diet and tap water ad libitum.
The test animals were acclimatized for two weeks and
put randomly in to five groups.
The parasite strain
The anti-malarial activity of the extract of E. kebericho
was tested using infected mice with chloroquine-sensitive
Plasmodium berghei strain ANKA, which are maintained
at the Animal House of the Department Biomedical
Sciences, AAU. The parasites were maintained by serial
passage from infected mice to non-infected mice on
weekly basis to maintain viability of the strain.
In vivo anti-malarial test
Antiplasmodial activity of the test extract was performed
in a four-day suppressive standard test [13]. An infected
blood sample was collected from the heart of a donor
mouse with a rising parasitaemia of about 30 %. The
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that each 0.2 ml contained approximately 1 × 107 P. ber-
ghei-parasitized erythrocytes. Male Swiss albino mice
weighing 25–32 g. were inoculated on first day (D0),
intraperitoneally, with 0.2 ml of infected blood. The mice
were then divided randomly into five groups of five mice
each for each group. Three groups of animals were
assigned as the test groups and the other two groups
were used as control (positive and negative). Three hours
after infection, the three test groups were orally adminis-
tered, with 200, 350 and 500 mg/kg/day doses of the root
extract. Chloroquine at the dose of 25 mg/kg/day (oral)
and an equivalent volume of vehicle (3 % of Tween 80)
was administered to the positive and negative control
groups, respectively, for four consecutive days (D0 to
D3). This was done for each group. On the fifth day (D4),
thin smears were made from the tail blood of each
mouse, fixed with methanol and stained with 10 % Giemsa.
The parasitaemia level was determined by counting the
number of parasitized erythrocytes out of 100 erythrocytes
in random fields of the microscope. Average percentage
parasitaemia was calculated using the formula:
% Parasitaemia ¼ Numberof infectedRBCs
Totalnumberof RBCs
 100
Average percentage of chemosuppression was calcu-
lated using the formula:
%Suppression ¼ Parasitaemia in negative control − Parasitaemia in test group
Parasitaemia innegativecontrol
 100
The body weights and packed cell volume (PCV) of
the mice were taken to observe whether the test extract
prevented the weight loss and reduction in PCV that are
commonly observed with increasing parasitaemia in
infected mice. The weight and PCV were taken at D0
and D4. The PCV was determined by the following
equation
PCV ¼ Volume of the total erythrocytes in a given volume of blood
Total blood volume
 100
Determination of the mean survival time
Mortality was monitored daily and the number of the
days from the time of inoculation of the parasite up toTable 1 Anti-malarial activity of different doses of Echinops keber
Treatment groups % survival of animal on day 10
Negative control 72.30 ± 2.37
200 mg/kg EKM 77.20 ± 2.51
350 mg/kg EKM 81.50 ± 1.40
500 mg/kg EKM 95.80 ± 1.86*
25 mg/kg CQ 100.00 ± 0.00*
Results are expressed as means ± S E M, n = 5. *P < 0.001 versus negative controldeath was recorded for each mouse in the treatment and
control groups throughout the follow-up period. The
mean survival time (MST) for each mouse was recorded
after the treatment periods.
Test for acute oral toxicity studies
Acute toxicity study was performed on mice of either
sex selected at random. The animals were fasted over-
night and provided with only water. They were then
divided into four groups, six animals in each group
(three male and three female), after which the fraction
was administered orally at increasing dose level of 2,000,
3,500, 5,000 mg/kg via oral gavage as per guidelines sug-
gested by the Organization for Economic Cooperation
and Development (OECD) [14]. Animals were kept under
close observation for four hours after administering the
extract for behavioural, neurological and autonomic pro-
file and observed for any change in general behaviour
and/or other physical activities and mortality within
24 hours.
Statistical analysis
The results were presented as the mean ± SEM (standard
error of mean) for each group of experiments. Data on
parasitaemia, body weight, PCV, and survival times were
analysed using Windows SPSS Version 20. Statistical
significance was determined by one-way analysis of vari-
ance (ANOVA), and independent t-tests. All data were
analysed at a 95 % confidence interval.
Results
Acute oral toxicity test
Acute toxicity studies conducted revealed that the ad-
ministration of graded doses of hydro-alcoholic extract of
E. kebericho (up to a dose of 5,000 mg/kg) did not pro-
duce significant changes in behaviours, such as alertness,
motor activity, breathing, restlessness, diarrhoea, convul-
sions, coma, and appearance of the animals. No death
was observed up to the dose of 5 g/kg body weight, indi-
cating that the medium lethal dose (LD50) could be
greater than 5 g/kg body weight in mice. The mice were
physically active. These effects were observed during the
experimental period.icho roots against Plasmodium berghei in Swiss albino mice
% parasitaemia % chemosuppression
62.40 ± 2.94 00.00 ± 0.00
51.83 ± 4.93 16.93 ± 1.17
44.02 ± 0.72* 29.46 ± 1.93
26.65 ± 1.01* 57.29 ± 1.76
00.00 ± 0.00* 100.00 ± 0.00
Table 2 Body weight of Plasmodium berghei-infected mice before and after the administration of the test extract of roots of
Echinops kebericho
Treatment groups Before treatment Weight (g) after treatment % change
Negative control 29.14 ± 0.26 28.64 ± 0.21 −1.72 ± 0.24
200 mg/kg EKM 28.90 ± 0.18 27.62 ± 0.40 −4.43 ± 0.22
350 mg/kg EKM 29.28 ± 0.27 28.12 ± 0.31 −3.96 ± 0.28
500 mg/kg EKM 29.06 ± 0.18 28.46 ± 0.30 −2.06 ± 0.21
25 mg/kg CQ 28.74 ± 0.11 31.08 ± 0.27* +8.14 ± 0.16
Results are expressed as means ± S E M, n = 5. *P <0.001 versus negative control
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the ethanol extract of the roots of E. kebericho produced
the highest chemosuppression in a dose-dependent man-
ner as compared to the negative control in this study.
The chemosuppression was 16.93 ± 1.17 %, 29.46 ± 1.93 %
and 57.29 ± 1.76 % for 200, 350, 500 mg/kg/day doses,
respectively (Table 1). The chemosuppressive effect pro-
duced by doses beyond 350 mg/kg was very significant
(P <0.001) compared with the negative control.
Comparison of the mean survival time of mice in the
experimental groups with the untreated group for all test
groups was performed (Table 1). The result indicated
that mice treated with all doses of extract lived longer
than the negative control. All concentrations of extract
employed in this study have no significant prevention
effect on weight loss of mice at all dose levels (p >0.05)
compared with the control group (Table 2). All the test
extracts employed in this study have significantly pre-
vented PCV loss of mice at all dose levels (P <0.001)
compared with the control group (Table 3).
Discussion
Plant products are frequently considered to be less toxic
and have fewer adverse effects than synthetic ones. A
growing number of peoples are therefore turning to al-
ternative therapy, including plant medicines. Traditional
Chinese medicine has been used in clinical practice for
several centuries. However, the compounds and precise
mechanisms of most plant medicines remain to be
determined.
Plasmodium species that cause human disease are
essentially unable to infect non primate animal models.Table 3 Packed cell volume (PCV) of Plasmodium berghei-infected
of roots of Echinops kebericho
Treatment groups Before treatment
Negative control 50.34 ± 0.93
200 mg/kg EKM 52.78 ± 1.58
350 mg/kg EKM 53.26 ± 1.52
500 mg/kg EKM 51.73 ± 0.48
25 mg/kg CQ 50.40 ± 0.39
Results are expressed as means ± S E M, n = 5. *P < 0.001 versus negative controlTherefore, for the in vivo evaluation of anti-malarial
compounds in rodents, the rodent malaria parasite is
employed, due to the sensitivity of P. berghei parasite to
chloroquine [15]. A four-day suppressive test was used
to assess the efficacy of the extract by comparison of
blood parasitaemia and mouse survival time in treated
and untreated mice.
The evaluation of anti-plasmodial activity of hydro-
ethanolic root extract of E. kebericho on early malaria in-
fection, in a four-day suppressive test, shows a statistically
significant parasitaemia suppression of 57.29 ± 1.76 % at
the highest dose, with the longest survival time compared
to all other doses and the negative control. By showing
the highest parasitaemia, chemosuppression and longest
survival time, it suggests that 500 mg/kg body weight of
extract might be the optimal therapeutic dose in mice.
The prolonged MST of the mice indicates that the extract
suppressed P. berghei and reduced the overall pathologic
effect of the parasite. The decrease in parasitaemia with
increasing concentration of the extract reflects an inhibi-
tory activity on parasite replication. These results indicate
significant anti-malarial potential for isolating a purer
compound [16–18].
In a four-day suppressive test, it was only chloroquine-
treated mice that prevented body weight loss significantly
(P <0.001). No extract-treated mice showed significant
(P >0.05) prevention against body weight loss when com-
pared to negative control. Body weight loss in extract-
treated mice might possibly be due to a depressing effect
of the crude extract on food intake or appetite. This
result is in agreement with that of a previous study on
other medicinal plants [17, 18].mice before and after the administration of the test extract
PCV (%) after treatment % change
40.68 ± 0.91 −19.12 ± 0.14
50.34 ± 1.51* −4.62 ± 1.11
52.34 ± 1.50* −1.73 ± 1.15
49.41 ± 0.64* −4.48 ± 0.52
52.30 ± 0.45* +3.77 ± 0.42
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of high destruction of red blood cells. The anaemia that
may result can be life threatening [18, 19]. During the
four-day suppressive test, the effect of the hydro-
ethanolic root extract of E. kebericho on the PCV was
tested to assess the reversing effect of the extract from
infection induced anaemia. The 200, 350 and 500 mg/kg
body weight of extract showed significant prevention
against PCV reduction (p <0.001). This may be due to
the effect of the extract in preventing PCV on early infec-
tion. Chloroquine showed a strong protective effect in
preventing PCV reduction compared to extract-treated
groups and negative control.
Another observation drawn from this study is the rela-
tive safety of the hydro-ethanolic extract of E. kebericho
roots at the graded dose of up to 5,000 mg/kg. Accord-
ing to Garner and coworkers, any compound or drug
with an oral LD50 estimate greater than 1,000 mg/kg
could be considered low toxic and safe [20]. Arising
from this, the E. kebericho at an oral dose of 5,000 mg/kg
can be considered relatively safe on acute exposure.
Conclusion
This study demonstrated the anti-malarial activity of etha-
nol extract of E. kebericho roots against P. berghei in an
animal model. The findings of this study confirm the trad-
itional usage of the plant to combat malaria in Ethiopian
folk medicine. These results suggest that it is possible to
isolate active anti-malarial compounds from the extract.
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